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ABSTRACT The pathological manifestation of nine hereditary neurodegenerative diseases is the presence within the brain of
aggregates of disease-speciﬁc proteins that contain polyglutamine tracts longer than a critical length. To improve our
understanding of the processes bywhich polyglutamine-containing proteinsmisfold and aggregate, we have conductedmolecular
dynamics simulations of the aggregation of model polyglutamine peptides. This work was accomplished by extending the PRIME
model to polyglutamine. PRIME is an off-lattice, unbiased, intermediate-resolution protein model based on an amino acid
representation of between three and seven united atoms, depending on the residue being modeled. The effects of hydrophobicity
on the system are studied by varying the strength of the hydrophobic interaction from 12.5% to 5% of the hydrogen-bonding
interaction strength. In our simulations, weobserve the spontaneous formation of aggregates and annular structures that aremade
up of b-sheets starting from random conﬁgurations of random coils. This result was interesting because tubular protoﬁbrils were
recently found in experiments on polyglutamine aggregation and because of Perutz’s prediction that polyglutamine would form
water-ﬁlled nanotubes.
INTRODUCTION
The pathological manifestation of nine hereditary neurode-
generative diseases, including Huntington’s disease, is the
presence within the brain of aggregates of disease-speciﬁc
proteins that contain polyglutamine tracts longer than a
critical length (1,2). In the case of Huntington’s, the as-
sociated protein is called Huntingtin. Although the causative
link between the aggregation of polyglutamine-containing
proteins and these so called ‘‘polyglutamine diseases’’ has
not yet been ﬁrmly established, protein aggregation is widely
believed to play a key role. Evidence pointing toward such a
link includes the observations that the diseases occur only
when the protein’s polyglutamine tract is longer than a
certain critical length (1,3–13) and the proteins aggregate in
vitro and in vivo only when their polyglutamine tract is
longer than a critical value (14–21). Furthermore, the ag-
gregation proceeds via a nucleation and growth mechanism
that speeds up as the length of the polyglutamine stretch in-
creases (16,22–24); this may explain why the diseases
manifest themselves in their victims at earlier ages as the
length of the polyglutamine sequence increases.
The molecular mechanisms by which the proteins impli-
cated in the polyglutamine diseases aggregate is still unclear.
To shed light on these mechanisms and to improve our under-
standing of the processes by which polyglutamine-contain-
ing proteins misfold and aggregate, we have conducted
molecular dynamics simulations of the aggregation of model
polyglutamine peptides. Although some work has been done
on simulating isolated polyglutamine molecules (25,26) and
dimers of polyglutamine (27), to our knowledge these are the
ﬁrst molecular simulations of the aggregation of large sys-
tems of polyglutamine peptides.
Our simulations have been conducted using an interme-
diate-resolution protein model developed in our lab, PRIME,
which is extended here to represent polyglutamine. PRIME
was ﬁrst introduced by Smith and Hall (28–31) and later
improved by Nguyen et al. (32); it has the advantage of
capturing the essential features of the forces responsible for
protein folding, such as the hydrophobic effect and hydrogen
bonding, yet can still be used to simulate large systems at
long timescales in a reasonable time. It stands at the cross-
roads between the ‘‘all-atom’’ models that account for the
motions of every atom on the protein being simulated, as
well as every solvent atom, and the more coarse-grained
models that simply represent amino acid residues or groups
of amino acid residues as beads on a lattice.
Proteins containing polyglutamine tracts are thought to
form b-sheets that are stabilized by hydrogen bonds not only
between backbone atoms but also between atoms on glu-
tamine side chains (33). This was ﬁrst suggested by Max
Perutz based on atomic-level models that showed that if
polyglutamine were folded into an antiparallel b-sheet, the
side-chain groups would be positioned so that an amino
group on one strand could donate a hydrogen bond to a car-
bonyl group on the next strand (34). In this structure, the side
chains lie above and below the plane of the b-sheet so that
every hydrogen-bond donor on one side chain is matched
with a hydrogen-bond acceptor on the next side chain (34).
Polyglutamine has been found to form b-sheets by a vari-
ety of experimental techniques including circular dichroism,
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electron microscopy, and x-ray diffraction (35,36). Bevivino
et al. (37) used infrared spectroscopy, circular dichroism, and
electron microscopy to examine the structure of an ataxin-3
protein with an expanded polyglutamine tract and found that
the polyglutamine regions adopt b-sheet structures. They
also showed, using atomic-level molecular modeling, that
the strands of the b-sheet need to be parallel to match every
hydrogen-bond donor with a hydrogen-bond acceptor. Tanaka
et al. (38) used circular dichroism, infrared spectroscopy, and
electron microscopy to show that glutamine repeats adopt
b-sheet structures when inserted into myoglobin. They pro-
posed that the b-sheets are antiparallel and that when the
polyglutamine sequence becomes too long, the b-sheets move
to the surface of the protein, where they can more readily
form intermolecular aggregates with corresponding b-sheets
on other molecules. Scherzinger et al. (39) used electron
microscopy to study the structure of aggregates formed
from Huntington containing an expanded polyglutamine
tract and found that these aggregates are ﬁbrillar. Cooper
et al. (40) stained protein fragments that contain expanded
polyglutamine tracts with Congo Red dye and examined
them with polarized light microscopy to show that they have
b-sheet conformations. Chen et al. (24) used circular
dichroism to show that synthetic polyglutamine peptides
exist in b-sheet conformations.
Based on analysis of x-ray crystallographic data, Perutz et al.
(41) recently suggested that polyglutamine could formb-sheets
with strands that wind around to form nanotubes. The nano-
tube idea led naturally to the following explanation for the
dependence of polyglutamine aggregation on tract length.
Polyglutamine tracts of 40 residues or longer could form two
turns within the nanotube structure; these would be stabilized
through hydrogen bonding between the turns. This double-turn
structure could then serve as a nucleus for growth of a
nanotube. Polyglutamine tracts shorter than 40 residues would
not be able to adopt the whole two-turn structure; structures
formed by such peptides would be less stable since they would
have fewer hydrogen bonds (41). This prediction is controver-
sial and the x-ray diffraction patterns have recently been
reinterpreted (42) to suggest that the peptides are in a stacked
b-sheet conformation similar to the classical ﬁbril structure
(43). Recently, Sharma et al. (44) collected new x-ray diffrac-
tion data on polyglutamine aggregates and suggested that
polyglutamine b-sheets stack to form slablike ﬁbrils.
Annular structures have been observed experimentally in
aggregating systems of polyglutamine and other proteins
associated with diseases of the brain. Wacker et al. (45) used
atomic force microscopy to examine aggregates formed from
huntingtin containing a polyglutamine tract 53 residues in
length and found annular structures that were themselves
made up of smaller annular structures. Lashuel et al. (46) used
electron microscopy to examine mutant a-synuclein proteins
that are linked to Parkinson’s disease and found annular
structures. Ding et al. (47) used atomic force microscopy to
examine a-synuclein and also found annular structures.
Theb-sheets formed by polyglutamine-containing proteins
assemble via a nucleated process in which the rate-limiting
step is the formation of the ﬁrst small section of b-sheet
structure, after which the b-sheet grows quickly (16,22–24).
Experimental support for this mechanism is as follows.
Aggregation increases when the concentration of polyglut-
amine-containing proteins increases. This is consistent with a
nucleation-dependentmechanism, because nucleus formation
is more probable at higher concentrations (16,18). Further-
more, aggregation of polyglutamine-containing proteins is
preceded by a so-called lag time, the time it takes for the
nucleus to assemble. After that, aggregation proceeds rapidly
as the nucleus grows (16,24,48). The lag time depends on
the concentration of the aggregating protein: the higher the
concentration, the more likely the nucleus is to form and
the smaller the lag time (16). The lag time also depends on the
length of the polyglutamine tract; longer polyglutamine
peptides tend to have shorter lag times (48). Nucleation of
polyglutamine aggregates can also be ‘‘seeded’’ by adding
small amounts of aggregated polyglutamine (1,16,24).
Simulations have been used to study the folding of isolated
polyglutamine peptides and the dimerization of small systems
of two polyglutamine peptides. Starikov et al. (25) examined
the structure of a 40-residue polyglutamine protein using three
different all-atom simulation codes, CHARMM,AMBER, and
OPLSAA. The protein folded into a b-sheet when CHARMM
was used and into a compact random coil when the two other
packages were used. The simulated b-sheet exhibited inter-
strand hydrogen bonding between donors and acceptors on the
backbone but more intra- than interstrand hydrogen bonding
between sites on the side chains. In the compact random coil
they found many side chain-side chain hydrogen bonds. They
suggested that polyglutamine chains longer than a critical chain
length fold into b-hairpins, which then aggregate if the con-
centration is high enough for nucleation.
Finke et al. (26) developed a united-atom model for poly-
glutamine in which each residue is represented by two beads,
one for the backbone atoms and another for the side-chain
atoms. They parameterized their model so that it would agree
with experiments that they conducted on CI2 proteins with
polyglutamine insertions. The strengths of the various inter-
actions in their model were adjusted so that the simulated
change in stability between the CI2 protein and the CI2 pro-
tein with a polyglutamine insertion would agree with the
change in stability determined experimentally. They then used
their model to simulate a single CI2 protein with poly-
glutamine insertions and concluded that isolated short poly-
glutamine peptides should exist as random coils.
Stork et al. (27) used fully atomistic CHARMM simula-
tions with explicit water molecules to measure the stability of
various conﬁgurations of polyglutamine 56 and 60 residues
long, as well as of two polyglutamine chains each 36 residues
long. They started their simulations in two of the conforma-
tions that polyglutamine has been postulated to adopt, the
nanotube and the b-helix. The nanotube conﬁguration is the
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conﬁguration suggested by Perutz that was discussed earlier.
The b-helix is similar to the nanotube except that the helix is
shaped like a triangle (as opposed to being circular), with
straight portions separated by three sharp turns. Stork et al.
determined the stability of these conﬁgurations based on
whether the peptides unfolded or remained in a particular con-
ﬁguration. They found that none of the tube conﬁgurations
were stable, but that a b-helical peptide with three helical
repeats of 18 residues and a dimer of two b-helical petides,
each with two helical repeats of 18 residues, were stable.
In this article, we describe the extension of PRIME
(32,49–51) (previously used to describe polyalanine) to the
description of polyglutamine and present our ﬁndings on the
aggregation of systems of 24 and 48 polyglutamine peptides
that are 16 residues long. PRIME uses discontinuous
potentials to take advantage of discontinuous molecular dy-
namics (DMD), a simulation technique that is very fast
compared to traditional molecular dynamics calculations.
Our simulations are started from random conﬁgurations of
random coils at high temperatures and slowly cooled to the
simulation temperature. Simulations are performed in the ca-
nonical ensemble with ﬁxed number of particles, system
volume, and temperature. The number of particles and sys-
tem volume are picked to give a ﬁxed concentration of 5
mM. The effects of hydrophobicity on the system are studied
by varying the strength of the hydrophobic interaction from
12.5% to 5% of the strength of the hydrogen-bonding in-
teraction. We monitor the aggregation of the polyglutamine
peptides over a wide range of temperatures. Aggregation and
aggregate structure are monitored by calculating the number
of b hydrogen bonds, the percent of the peptides in b-sheets,
and the number of b-regions in the system.
Highlights of our results include the following. At in-
termediate values of temperature we observed the spontane-
ous formation of b-sheets and annular structures made up of
b-sheets. These annular structures resemble nanotubes and
b-barrels. The number of peptides in b-sheets decreases with
increasing temperature. At the very highest temperatures, the
system does not fold or aggregate; it remains a system of
isolated random coils. At low temperatures, amorphous ag-
gregates are formed.
The organization of this article is as follows. In Methods,
the peptide model and the simulation method are described.
In Results, we present our results on the formation of
b-sheets, the formation of annular structures made up of
b-sheets, and the effects of hydrophobicity on the aggrega-
tion of our model polyglutamine peptides. The last section
contains a discussion of our results.
METHODS
Model forces
In this work, we extend the protein model PRIME (PRotein Intermediate
resolution ModEl) to polyglutamine. PRIME was originally developed by
Smith and Hall (28–31), inspired by the work of Takada et al. (52), and
improved upon by Nguyen et al. (32). This model is designed to be used with
a simulation technique known as discontinuous molecular dynamics (DMD)
(53–55), an extremely fast alternative to traditional molecular dynamics.
DMD simulations are appropriate for systems with discontinuous potentials
such as hard-sphere and square-well potentials, where the forces operating
on the molecules change only at speciﬁc points in time and space when the
particles collide. In contrast, the forces in traditional molecular dynamics
simulations (which are based on continuous potentials) change at all points
in space and time. DMD simulations are much faster than traditional mo-
lecular dynamics simulations because Newton’s laws can be solved ana-
lytically instead of by numerically integrating the potentials. Furthermore,
the time course of the simulation is not restricted to small, equally spaced
time steps as is the case with traditional molecular dynamics; instead, the
entire system can advance in time to the next discontinuity in the potential,
which is referred to as an ‘‘event.’’
PRIME is an off-lattice, unbiased, intermediate-resolution protein model
(28–32) that has thus far been applied mainly to polyalanine. Each amino
acid residue is composed of a three-sphere backbone comprised of united
atoms NH, CaH, and C¼O. An alanine side chain is represented by one
sphere. PRIME has realistic bond lengths and bond-angle constraints and
has the ability to interact both intra- and intermolecularly via hydrogen
bonding and hydrophobic interaction potentials. All backbone bond lengths
and bond angles are ﬁxed at their ideal values; the distance between con-
secutive Ca atoms is ﬁxed so as to maintain the interpeptide bond in the trans
conﬁguration. The side chains are held in positions relative to the backbone
so that all residues are L-isomers. The effect of solvent is factored into the
energy function as a potential of mean force.
All forces are modeled by discontinuous potentials. The excluded
volumes of the united atoms are modeled using hard-sphere potentials with
realistic diameters. Covalent bonds are maintained between adjacent spheres
along the backbone by imposing hard-sphere repulsions whenever the bond
lengths attempt to move outside of the range between (1 d)‘ and (11 d)‘,
where ‘ is the bond length and d is a tolerance that we set to 2.5%. Ideal
backbone bond angles, Ca-Ca distances, and residue L-isomerization are
achieved by imposing pseudobonds, which also ﬂuctuate within a tolerance
of 2.5%. Interactions between hydrophobic side chains are represented by a
square-well potential of depth eHP and range 1.5sR where sR is the side-
chain united-atom diameter. Hydrophobic side chains must be separated by
at least one intervening residue to interact. Hydrogen bonding between
amide hydrogen atoms and carbonyl oxygen atoms on the same or
neighboring chains is represented by a square-well potential of depth eHB
between NH and C¼O united atoms whenever 1), the virtual hydrogen and
oxygen atoms (whose location can be calculated at any time) are separated
by 4.2 A˚ (the sum of the NH and C¼O well widths); 2), the nitrogen-
hydrogen and carbon-oxygen vectors point toward each other within a fairly
generous tolerance; 3), neither the NH nor the C¼O are already involved in a
hydrogen bond with a different partner; and 4), the NH and C¼O are
separated by at least one intervening residue along the chain. We allow
hydrogen bonds between groups separated by one intervening residue along
the chain because this reproduces the distributions of separations along the
chain of hydrogen-bonding pairs observed in structures from the Protein
Data Bank by Stickle et al. (56). To satisfy the requirement that the nitrogen-
hydrogen and carbon-oxygen vectors point toward each other, we used the
approach of Nguyen et al. (32) but the parameter set of Ding et al. (57). This
parameter set allows formation of hydrogen bonds at all temperatures while
still reproducing the hydrogen-bond angle and distance distributions of
Smith and Hall (29). The reason we did not use the parameter set of Nguyen
et al. (32) is that b-sheets formed in simulations with that parameter set at
temperatures just below the b-sheet/random coil transition temperature were
unphysical in that they had very few hydrogen bonds. This happened in our
polyglutamine simulations but not in the polyalanine simulations of Nguyen
and Hall (49–51), because the additional hydrophobic bead on the
polyglutamine side chains held the polyglutamine b-strands together in a
b-sheet-like structure at higher temperatures and this parameter set makes it
harder for hydrogen bonds to form at high temperatures. Since b-sheets with
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few hydrogen bonds are physically unrealistic, we used the parameter set of
Ding et al. (57). We deﬁne the reduced temperature, T* as kT/eHB and the
relative hydrophobicity, R, as eHP/eHB.
PRIME is extended topolyglutaminebyadopting amore complex side chain
representation. We considered a variety of approaches, including a two-sphere
representation, but eventually settled on a four-sphere side-chain representation
since this gives the most faithful representation of the geometry of glutamine
side chains. The four-sphere representation allows us to model the polyglut-
amine side chain with the same level of detail as the PRIME model backbone.
Each side chain is represented by four spheres, as depicted in Fig. 1. Spheres
1 and 2 (as labeled in Fig. 1) each represent a methylene group and have hard
cores that are surrounded by square wells to mimic excluded volume and
hydrophobic interactions. Sphere 3 represents a carbonyl group; it has a hard
core to mimic excluded volume and a directionally dependent square well to
mimic a hydrogen-bond acceptor. Sphere 4 represents an amine group; it has a
hard core to mimic excluded volume and a directionally dependent square well
to mimic a hydrogen-bond donor. The four spheres all have their bond angles
constrained by a system of pseudobonds. The methyl, carbonyl, and amine
groups on the polyglutamine side chain are modeled in the same way as the
methyl, carbonyl, and amine groups in the polyalanine PRIME model and, as
such, have exactly the same sizes, bond lengths, pseudobond lengths, inter-
action strengths, and interaction ranges.
Discontinuous molecular dynamics
DMD simulations are conducted as follows. Each sphere of the model
protein chain is assigned a random initial position that does not violate any
of the size constraints or assigned bond lengths and angles. It is also assigned
an initial velocity chosen at random from a Maxwell-Boltzmann distribution
at a speciﬁed reduced temperature, T*. The simulation proceeds according to
the following schedule: identify the ﬁrst event, move forward in time until
that event occurs, calculate new velocities for the pair of spheres involved in
the event and calculate any changes in system energy resulting from hy-
drogen bond events or hydrophobic interactions, ﬁnd the second event, and
so on. Types of events include excluded-volume events, covalent-bond
events, pseudobond events, square-well hydrogen-bond events, and square-
well hydrophobic-interaction events. An excluded-volume event occurs when
the surfaces of two hard spheres collide and repel each other. A bond (or
pseudobond) event occurs when two adjacent spheres attempt to move out-
side of their assigned bond length and the two particles feel an inﬁnite
repulsion that forces them back into their assigned bond length. Square-
well events include well-capture, well-bounce, and well-dissociation
‘‘collisions’’ when a sphere enters, attempts to leave, or leaves the square
well of another sphere. For more details onDMD simulations with square-well
potentials, see articles by Alder and Wainwright (53) and Smith et al. (58).
The simulations were performed in the canonical ensemble, which means
that the number of particles, volume, and temperature are held constant. The
number of particles and box volume were picked to give the desired con-
centration. Between three and ﬁve simulations were run at every data point.
Simulations of 24chainswere run for 30billionDMDevents and simulations of
48 chains were run for 80 billion DMD events, to ensure that a stable structure
was formed. Properties were averaged over the last 2 billion DMD events, and
error bars represent the standard deviation between all the runs at a given state
point. Periodic boundary conditions were used to eliminate artifacts due to
simulation box walls. The Andersen thermostat (59) was used to maintain
constant temperature; in this method, all the particles experience random,
infrequent eventswhere they are given a newvelocity selected randomly froma
Maxwell-Boltzmann distribution centered at the simulation temperature. These
events are referred to as ‘‘ghost collisions’’ or collisionswith ‘‘ghost particles.’’
Systems containing 24 and 48 chains at a concentration of 5 mM were
slowly quenched from a random conﬁguration of high-temperature random
coils at T* ¼ 0.5 to the temperature of interest, which ranged from T* ¼
0.075 to T*¼ 0.205. Simulations at relative hydrophobicity R¼ 0.05, 0.075,
0.1, and 0.125 were performed to learn how the strength of this interaction af-
fects the self-assembly of the peptides in the system. We monitored the
number of b backbone-backbone hydrogen bonds, which we deﬁne as
hydrogen bonds in which both the donor and acceptor backbone dihedral
angles, f and c, adjacent to the hydrogen bond lie in the range 0# c# 180
and –180 # f # –30. This range for the dihedral angles is the same as that
used by Nguyen et al. (32). We also monitored the number of backbone-
backbone, side chain-side chain, and side chain-backbone hydrogen bonds,
as well as the fraction of peptides in b-sheets and the number of b-regions
(deﬁned below). The fraction of peptides in b-sheets was calculated based
on the following deﬁnitions. A b-sheet is deﬁned as a structure in which two
or more peptides share a number of b hydrogen bonds between them that is
greater than or equal to half the chain length (eight hydrogen bonds in the
case of our 16-residue chains). This deﬁnition emerged from the observation
that if two peptides are perfectly aligned, the number of hydrogen bonds
between them could equal the chain length. Although the N and C spheres
associated with each residue could both form hydrogen bonds, the direction
in which the residues face alternates along the chain from facing the peptide
in question to facing away from the peptide in question. Thus, the maximum
possible number of hydrogen bonds between them would equal the chain
length. The fraction of peptides in b-sheets is the number of peptides
involved in b-sheet structures divided by the total number of peptides in the
system. We were also interested in the contiguousness of the b hydrogen
bonds, so we deﬁned a b-region to be a section in an aggregate where two
neighboring peptides share at least ﬁve b hydrogen bonds in a row. Since the
residues alternate between facing toward and away from each other, the term
‘‘in a row’’ does not include the two hydrogen bonds formed when the
residues in question face away from each other. Thus, ﬁve in a row means
hydrogen bonds formed by Ni, Ci, Ni12, Ci12, Ni14, or Ci, Ni12, Ci12, Ni14,
Ci14, where i is the residue number along the chain.
FIGURE 1 Four-sphere representation of a polyglutamine side chain.
Hard spheres are white. Square wells representing hydrophobic interactions
are shown in a honeycomb pattern. Square wells representing hydrogen-
bond acceptors have thick horizontal stripes and square wells representing
hydrogen-bond donors have thin vertical stripes. Covalent bonds are shown
in bold and pseudobonds to constrain bond angles are thin lines.
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RESULTS
DMD simulations were performed on systems containing 24
and 48 16-residue polyglutamine chains to see if they would
form ﬁbrils. We chose a chain length of 16 because Nguyen
and Hall (49) found that systems containing polyalanine
chains 16 residues long that were initially in random coil
conformations spontaneously formed ﬁbrils as the simula-
tions progressed. We found that as our simulations pro-
gressed the polyglutamine peptides folded into b-sheets that
tended to curve. When there were enough peptides in the
system, the b-sheets rolled up into a tubelike structure that
resembled a classic b-barrel. Snapshots of one of the re-
sulting tube structures are shown in Fig. 2. The tube in this
ﬁgure contains 11 peptides and has an inner diameter of 17–
18 A˚, an outer diameter of 41–43 A˚, and a height of 30–45 A˚.
We observed a variety of tube morphologies in our sim-
ulations, including tubes with large diameters (Fig. 3 A),
tubes that are connected to each other (Fig. 3 B), and tubes
connected to b-sheets (Fig. 3 C). The large tube shown in
Fig. 3 A has an inner diameter of 32–39 A˚, an outer diameter
of 55–62 A˚, and a height of 43–49 A˚.
We examined the self-assembly of these structures at
relative hydrophobicity values of R ¼ 0.005, 0.075, 0.10,
and 0.125 to ﬁnd a reasonable value for this parameter,
which is the only adjustable parameter in the model. It is
difﬁcult to assign a value to this parameter a priori, because
we are coarse-graining away detail not only about the
hydrogen-bond donors and acceptors but also about the
solvent molecules. Since little is known about the molecular-
level structure of polyglutamine aggregates, besides that they
are made up of b-sheets (at this point a controversy exists as
to whether these b-sheets form ringlike structures (41,45) or
slablike ﬁbrils (42,44)), it would be useful to know the value
of the relative hydrophobicity at which the system self-
assembles into the most ordered b-sheets. This value could
then be used in future simulations.
Fig. 4 shows the number of b intermolecular backbone-
backbone hydrogen bonds as a function of T* at the four dif-
ferent values of the relative hydrophobicity. At all R, the
system shows the following behavior as a function of the
reduced temperature. At low T*, the system has a small
number of b intermolecular hydrogen bonds, because it is in
a collapsed state that is relatively disordered. As T* in-
creases, the system forms more and more b intermolecular
hydrogen bonds because it has more ﬂexibility, which gives
it the freedom to ﬁnd more ordered states. At high T*, the
number of b intermolecular hydrogen bonds decreases as
temperature increases because entropy takes over and the
peptides become increasingly random-coil-like.
The value of the relative hydrophobicity, R, affects the
self-assembly of the peptides as follows. At the highest
values of the relative hydrophobicity (R¼ 0.125), the system
remains in a b-sheet conformation for higher values of T*
than it does at all the other values of the relative hydropho-
bicity. It also has fewer b intermolecular hydrogen bonds at
low temperatures than systems at intermediate values of the
hydrophobicity (R ¼ 0.1 and R ¼ 0.075). As the hydropho-
bic interaction decreases from R ¼ 0.125 to R ¼ 0.05, the T*
at which the system transitions from b-sheets to random coils
decreases. Additionally, as the hydrophobic interaction de-
creases from R¼ 0.1 toR¼ 0.05, the low value of T* at which
the peptides undergo a transition from b-sheets to amorphous
aggregates increases. Thus, the range of T* over which the
system self-assembles into b-sheets becomes narrower as the
FIGURE 2 (A) Snapshot of the whole system of 24 polyglutamine
16-mers at R ¼ 0.125, T* ¼ 0.155. (B) Close-up of the tube formed from
24 polyglutamine 16-mers at R ¼ 0.125, T* ¼ 0.155.
FIGURE 3 (A) Snapshot of large diameter tube formed by 24 polyglut-
amine 16-mers at R ¼ 0.125, T* ¼ 0.185. (B) Snapshot of connected tubes
morphology formed by 24 polyglutamine 16-mers at R¼ 0.125, T*¼ 0.185.
(C) Snapshot of tube connected to sheet morphology formed from 24 poly-
glutamine 16 mers at R ¼ 0.125, T* ¼ 0.165.
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hydrophobic interaction strength decreases. At low values of
the hydrophobic interaction (R ¼ 0.05), the peptides do not
self-assemble into b-sheets as well as they do at higher
values of R, because they do not have as many b inter-
molecular backbone-backbone hydrogen bonds as the sys-
tems at higher values of R. At high values of the hydrophobic
interaction (R ¼ 0.125) the peptides do not self-assemble
into b-sheets as well as they do at lower values of R, because
they get caught in kinetic traps more easily due to the
strength of the hydrophobic attraction.
To quantify the structure of the aggregates that are formed,
we have determined the fraction of peptides that are in
b-sheets and the number of b-regions in the system. Fig. 5
shows the fraction of peptides that are in b-sheets versus T*
for all the hydrophobic interaction strengths studied. Fig. 6
shows the number of b-regions versus T* for all the hydro-
phobic interaction strengths studied.
The trends seen in Fig. 4 are also seen in Figs. 5 and 6. At
low values of T*, the system is kinetically trapped in amor-
phous structures and hence all measures of b-sheet formation
are low. As T* increases, all of the curves go through a
maximum at an optimum temperature for b-sheet formation.
As T* increases further, the system undergoes a transition to
random coils because entropy is taking over. As the hydro-
phobicity increases, the temperature at which the transition
from b-sheets to random coils occurs increases and the tem-
perature at which the transition from b-sheets to amorphous
aggregates occurs decreases. This trend is not followed, how-
ever, at the highest value of the relative hydrophobicity, R ¼
0.125. In this case, the fraction of peptides in b-sheets is
generally lower than at the other values of the relative hy-
drophobicity. This happens because the system gets caught
in kinetic traps more easily due to the very strong hydro-
phobic interaction.
At intermediate values of the relative hydrophobicity, R ¼
0.1 and R ¼ 0.075, the peptides assemble into b-sheets at
intermediate values of reduced temperature T* ¼ 0.115 to
T* ¼ 0.155 almost equally well. The system at relative
hydrophobicity R ¼ 0.075 has slightly more b intermolecular
backbone-backbone interactions and b-regions than the
system at the hydrophobicity R ¼ 0.1 at reduced tempera-
tures of T* ¼ 0.135 and T* ¼ 0.145 but a lower fraction of
peptides in b-sheets. Based on these observations we believe
that the lower of these two relative hydrophobicities, R ¼
0.075, allows the system to make b-sheets that are more
ordered (based on having more b-regions) but smaller (based
on the fraction of peptides in b-sheets). Evidently, the hy-
drophobicity at R ¼ 0.1 is strong enough that it prevents the
peptides from optimally arranging into very well ordered
b-sheets and the hydrophobicity at R¼ 0.075 is weak enough
that the entire system does not aggregate into b-sheets.
To check to see if these trends would be followed for
larger systems, we performed simulations on larger systems
containing 48 polyglutamine 16-mers at R ¼ 0.075 and R ¼
0.10. We found similar behavior for the b intermolecular
FIGURE 4 b-intermolecular backbone-backbone hydrogen bonds versus
T* for the 24 polyglutamine 16-mers system.
FIGURE 5 Fraction peptides in b-sheets versus T* for the 24 polyglut-
amine 16-mers system.
FIGURE 6 Number of b-regions versus T* for the 24 polyglutamine
16-mers system.
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backbone-backbone hydrogen bonds and b-regions. How-
ever, the fraction of peptides in b-sheets was different in that
the maximum at R ¼ 0.075 was higher than the maximum at
R ¼ 0.10 (the opposite was the case for the smaller system).
This result can be seen in Fig. 7. We believe that this is be-
cause the larger systems are more prone to getting caught in
kinetic traps at high hydrophobicity. We conclude that the
relative hydrophobicity value R ¼ 0.075 is most appropriate
for future simulations with this model.
The peptides at the lowest value of the hydrophobicity,
R ¼ 0.05, are least likely to self-assemble into b-sheets. Our
explanation for this is that hydrophobicity, a side chain-side
chain interaction, which brings the side chains together
(when strong enough), promotes the formation of side chain-
side chain hydrogen bonds. Once the side-chain united atoms
have formed hydrogen bonds with other side-chain united
atoms they are unlikely to break and form hydrogen bonds
with backbone united atoms. This then permits the backbone
united atoms to form hydrogen bonds with other backbone
united atoms without interference from side-chain united
atoms. However, if the hydrophobicity is low, the side-chain
united atoms will be less likely to hydrogen-bond with other
side-chain united atoms, opening the door to hydrogen
bonding between side chain united atoms and backbone
united atoms. These side chain-backbone hydrogen bonds
interfere with the formation of backbone-backbone hydrogen
bonds, leading to the formation of more amorphous structures.
This increased side chain-backbone hydrogen bonding at
low values of the relative hydrophobicity (R ¼ 0.05) can be
seen by comparing the numbers of total backbone-backbone,
b backbone-backbone, side chain-side chain, and side chain-
backbone intermolecular hydrogen bonds plotted in Figs. 8
and 9 as a function of T* at R ¼ 0.075 and R ¼ 0.05,
respectively. At both values of hydrophobicity, as the re-
duced temperature decreases, the number of side chain-
backbone hydrogen bonds formed increases. The total
number of backbone-backbone hydrogen bonds and the
number of b backbone-backbone hydrogen bonds decrease
after going through a maximum at intermediate values of T*.
The system at the hydrophobicity of R¼ 0.075 is more likely
to form b-sheets at intermediate values of T* (as indicated by
the large numbers of b intermolecular backbone-backbone
hydrogen bonds at these T* values) than the system at the
hydrophobicity of R ¼ 0.05. This is because for R ¼ 0.05,
when T* is low enough to bring all the peptides in the system
together, too many side chain-backbone hydrogen bonds
form and at higher values of T*, the system forms small
b-sheets and random coils. At this low value of the relative
hydrophobicity, the peptides go from amorphous aggregates
dominated by side chain-backbone interactions at low values
of T* (as indicated by the large numbers of intermolecular
side chain-backbone hydrogen bonds at these T* values) to
the transition from one large aggregate to smaller and smaller
b-sheets and eventually random coils at higher T* values
FIGURE 7 Fraction peptides in b-sheets versus T* for the 48 polyglut-
amine 16-mers system.
FIGURE 8 Intermolecular hydrogen bonds versus T* at R¼ 0.075 for the
24 polyglutamine 16-mers system.
FIGURE 9 Intermolecular hydrogen bonds versus T* at R ¼ 0.05 for the
24 polyglutamine 16-mers system.
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(as indicated by the decrease in intermolecular backbone-
backbone hydrogen bonds as T* increases).
To determine the role played by the side chain-backbone
hydrogen bonding in the increased amorphous aggregation at
low values of relative hydrophobicity and temperature and in
the formation of annular structures, we performed simula-
tions with this interaction turned off. Side chain-side chain
and backbone-backbone hydrogen bonds were allowed, but
side chain-backbone hydrogen bonds were not. As can be
seen in Fig. 10, by comparing the ﬁlled-circle and asterisk
curves, removing the possibility of side chain-backbone
hydrogen bonding increased the number of b intermolecular
backbone-backbone hydrogen bonds, which means that the
structures were more ordered and therefore less amorphous.
Annular structures were also observed in these simulations.
We concluded that the side chain-backbone hydrogen bonds
were causing increased amorphous aggregation, and that
annular structures could be formed without these interactions.
We were also interested in the effects of the side chain-
side chain hydrogen bonding on the aggregation of our
model polyglutamine peptides so we performed simulations
with all of the side-chain hydrogen bonding turned off. In
this case, backbone-backbone hydrogen bonds were the only
hydrogen bonds allowed to form. As can be seen in Fig. 10,
there was an increase in the number of b intermolecular
backbone-backbone hydrogen bonds (curve with open
circles) compared to the number in the simulations with
side chain-backbone and side chain-side chain hydrogen
bonds allowed (curve with solid circles) and an increase
compared to the simulations performed with side chain-side
chain hydrogen bonds allowed but side chain-backbone
hydrogen bonds turned off (curve with asterisks). Annular
structures were also observed in these simulations. We
concluded that the side chain-side chain hydrogen bonding
was increasing the complexity of the energy landscape for
the system and therefore increasing kinetic trapping which
led to less ordered structures. Furthermore we concluded that
the side chain hydrophobicity and backbone-backbone hy-
drogen bonding were sufﬁcient for the formation of annular
structures by polyglutamine.
In developing the models used for polyglutamine, we
performed simulations of isolated polyglutamine peptides 16
residues long with the side-chain hydrogen-bonding inter-
actions both turned off and turned on. We found that when
the side chain hydrogen-bonding interactions were turned
on, the peptides folded into structures we call ‘‘collapsed
random coils’’, since they had few a or b backbone-
backbone hydrogen bonds. However, when the side-chain
hydrogen-bonding interactions were turned off, these pep-
tides folded into a-helices. Since evidence to date suggests
that polyglutamine does not fold to a unique conformation,
but instead adopts a random-coil conformation (24,60), we
believe that the polyglutamine model without side-chain
hydrogen bonding is not a good one, as the peptides will fold
into a-helices in this case.
In a set of simulations on a small system of eight
polyglutamine chains 16 residues long with all of the side-
chain hydrogen bonding turned off and the hydrophobicity
of the g-side chain methyl group (the second sphere from the
backbone on the side chain) turned off, we noticed that the
peptides did not aggregate. Instead, there was a transition
from a-helices directly to random coils as temperature was
increased. This means that both methyl groups on the side
chain need to have the hydrophobic interactions for the
model polyglutamine peptides to form b-sheets and annular
structures.
We believe that the lack of an attraction between the side-
chain end groups (the amine spheres) is what is leading to the
formation of annular structures by our model polyglutamine
molecules as opposed to the slablike ﬁbril structures that were
formed in the simulations of Nguyen and Hall (49–51). In the
simulations with all of the side-chain hydrogen bonding
turned off, the carbonyl and amine spheres behaved as hard
spheres. Essentially, because there was no attraction between
these side chain end groups there was no force driving the
b-sheets to stack. Instead they formed one large b-sheet,
which then rolled into an annular structure to avoid having
exposed b-sheet ends (which are energetically unfavorable
because of unsatisﬁed hydrogen bonds). To test this idea, we
are currently developing a model in which the carbonyl and
amine spheres interact via a square-well attraction to mimic
van der Waals forces to see what effects this will have on the
structures formed as the peptides aggregate.
DISCUSSION
Our short polyglutamine chains formed b-sheets that curved
to make nanotubes. This result was interesting because
tubular protoﬁbrils were recently found in experiments on
FIGURE 10 b-Intermolecular backbone-backbone hydrogen bonds ver-
sus T* for the polyglutamine 16-mers system at R ¼ 0.1 with all side-chain
hydrogen bonding turned on (solid circles), side chain-backbone hydrogen
bonding turned off (asterisks), and all side-chain hydrogen bonding turned
off (open circles).
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polyglutamine aggregation (45) and in experiments on the
protein responsible for Parkinson’s disease, a-synuclein
(46,47), and because of the growing interest in using proteins
in nanoscience (61–73). Our results are also intriguing given
the prediction of Perutz et al. that polyglutamine should form
water-ﬁlled nanotubes (41). Although this prediction was
made for polyglutamine peptides 40 residues long and sug-
gested a tube diameter of 11.8 A˚, our ﬁnding that our model
polyglutamine peptides 16 residues long formed tubes with
diameters of 17 A˚ is still interesting. Perutz et al. based their
prediction on x-ray scattering of aggregates of peptides con-
taining 15 glutamine residues, so our ﬁndings in simulations
of aggregation of polyglutamine peptides 16 residues long
are more comparable with their experimental results than
with their predictions of structures for polyglutamine pep-
tides 40 residues long. We wish to point out that this
prediction is controversial and that their x-ray diffraction pat-
terns have recently been reinterpreted (42) to suggest that the
peptides are in a stacked b-sheet conformation similar to the
classical ﬁbril structure (43). Likewise, recent x-ray diffrac-
tion work by Sharma et al. (44) has suggested that poly-
glutamine forms slablike ﬁbrils. Since this controversy exists
as to how polyglutamine b-sheets are organized in aggre-
gates, we are unable to conclusively verify our predicted
molecular structures for polyglutamine aggregates against
experimentally determined molecular structures. Hopefully
this situation will change in the near future, as research
workers begin to apply the powerful solid-state NMR
technique to polyglutamine-containing proteins.
It is important to point out the limitations of our model and
our methodology that arise because of compromises we have
made to be able to study protein aggregation within the limit
of today’s computational technology. The absence of explicit
water molecules in our simulations is a limitation, because it
does not allow us to account for hydrogen bonding between
backbone atoms and water molecules or between side-chain
atoms and water molecules. Furthermore, as Perutz et al.
predicted, the polyglutamine nanotube should be ﬁlled with
water, which means that water molecules could potentially
play an important role in these structures. The lack of at-
omistic detail does not allow us to accurately account for the
packing of all the atoms or predict the energetics of the
system with any accuracy. Finally our potential of mean
force for the hydrophobic effect does not change with tem-
perature. Nonetheless, the compromises that we have made
in model detail are necessary to be able to treat the large
system sizes and long timescales characteristic of aggrega-
tion phenomena.
We are currently performing simulations of longer chains
closer to the critical repeat length for Huntington’s disease to
contribute more directly to Huntington’s disease research.
These results will be presented in a forthcoming article.
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continuous molecular dynamics simulations. We thank the North
Carolina State University High-Performance Computing Center for com-
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